华森制药: 关于公司控股股东及高级管理人员减持股份计划完成暨减持结果公告

Core Viewpoint - The announcement details the completion of the share reduction plan by the controlling shareholder and senior management of Chongqing Huason Pharmaceutical Co., Ltd, confirming that the reduction was executed in compliance with relevant regulations [1][4]. Shareholder Reduction Details - The controlling shareholder, Chengdu Local Construction Machinery Engineering Co., Ltd, reduced its holdings by a total of 12,527,826 shares, accounting for 3% of the company's total share capital, through a combination of block trading and centralized bidding [2][3]. - The price range for the shares sold by Chengdu Local Construction was between 14.51 and 19.29 yuan per share [2]. - Senior management member Peng Xiaoyan reduced her holdings by 4,300 shares, representing 0.0010% of the total share capital, through centralized bidding [2][3]. Compliance and Impact - The share reduction was conducted in accordance with the relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shenzhen Stock Exchange rules [4]. - The reduction plan will not lead to a change in the company's control and will not impact its ongoing operations [4][5].